Trials / NCT04765345
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
Underway, not enrolling Observational Natural history / observational
- Sponsor
- Jaeb Center for Health Research
- Treatment
- Not listed
- Gene
- PCDH15
- Conditions
- Retinal Degeneration, Retinitis Pigmentosa, Eye Diseases, Hereditary
- Ages
- 8 Years to no upper limit
- Enrollment
- 44 participants
- Started
- 2021-06-08
- Main results expected
- 2027-06-30
- Results posted
- Not yet
- Record last updated
- 2026-02-04
What the study is testing
The overall goal of this project, co-funded by the Foundation Fighting Blindness and the USHER 1F Collaborative is to characterize the natural history of disease progression in patients with PCDH15 mutations in order to accelerate the development of outcome measures for clinical trials.
Where it runs
Canada (1)
- Hospital for Sick Children, Toronto, Ontario
France (1)
- CHNO des Quinze-Vingts, Paris
Germany (1)
- University of Tubingen, Tübingen
Israel (1)
- Haddassah Medical Center, Jerusalem
Netherlands (1)
- Radboud University, Nijmegen
Switzerland (1)
- University Hospital Basel, Basel
United Kingdom (1)
- Moorfields Eye Hospital, London
United States (3)
- University of California, San Francisco, San Francisco, California
- The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland
- Duke University, Duke Eye Center, Durham, North Carolina